Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 146

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 146
---
 for illustrative purposes only, are based on certain assumptions, address a hypothetical situation and reflect limited historical financial data. Therefore, the unaudited pro forma combined financial statements are not necessarily indicative of the results of operations and financial position that would have been achieved had the Business Combination been consummated on the dates indicated above, or the future consolidated results of operations or financial position of OmnigenicsAI following the closing of the transactions contemplated by the Business Combination Agreement. Accordingly, the Combined Company’s business, assets, cash flows, results of operations and financial condition may differ significantly from those indicated by the unaudited pro forma combined financial statements included in this document. See “ Unaudited Pro Forma Combined Financial Information.” 49 A market for our securities may not continue, which would adversely affect the liquidity and price of our securities. Following the Business Combination, the price of our securities may fluctuate significantly due to the market’s reaction to the Business Combination and general market and economic conditions. An active trading market for our securities following the Business Combination may never develop or, if developed, it may not be sustained. In addition, the price of our securities after the Business Combination can vary due to general economic conditions and forecasts, our general business condition and the release of financial reports. Additionally, if, following the Business Combination, our securities are not listed on, or become delisted from, Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter -dealerautomated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if they were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained. If our securities are not listed on a national securities exchange, our investors would likely face significant and material adverse consequences with respect to their investment in us, including, but not limited: •a limited availability of market quotations for our securities; •reduced liquidity for our securities; •as discussed above, a determination that our ordinary shares are “penny stock”, which will require brokers trading in such ordinary shares to adhere to more stringent rules and which likely would serve as an additional factor that may reduce the trading activity in the secondary trading market for our securities; •a limited amount of news and analyst coverage with respect to our securities; and •a decreased ability to issue additional securities or obtain additional financing in the future, which may adversely impact our efforts to consummate a